| Target Price | $286.62 |
| Price | $285.72 |
| Potential | 0.31% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Marriott 2026 . The average Marriott target price is $286.62. This is 0.31% higher than the current stock price. The highest price target is $348.60 22.01% , the lowest is $207.05 27.53% . | |
| A rating was issued by 31 analysts: 13 Analysts recommend Marriott to buy, 17 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2026 of 0.31% . Most analysts recommend the Marriott stock at Hold. |
27 Analysts have issued a sales forecast Marriott 2025 . The average Marriott sales estimate is $26.5b . This is 2.21% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $28.6b 10.18% , the lowest is $25.3b 2.41% .
This results in the following potential growth metrics:
| 2024 | $25.1b | 5.85% |
|---|---|---|
| 2025 | $26.5b | 5.57% |
| 2026 | $28.0b | 5.57% |
| 2027 | $29.6b | 5.72% |
| 2028 | $30.0b | 1.45% |
| 2029 | $30.8b | 2.50% |
| 2030 | $34.3b | 11.66% |
| 2031 | $35.2b | 2.54% |
| 2032 | $36.6b | 3.83% |
27 Analysts have issued an Marriott EBITDA forecast 2025. The average Marriott EBITDA estimate is $5.4b . This is 24.63% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.7b 30.46% , the lowest is $5.2b 20.36% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $4.0b | 2.09% |
|---|---|---|
| 2025 | $5.4b | 34.22% |
| 2026 | $5.8b | 6.59% |
| 2027 | $6.2b | 7.15% |
| 2028 | $7.2b | 16.31% |
| 2029 | $7.6b | 6.30% |
| 2030 | $8.2b | 7.56% |
| 2031 | $8.6b | 4.34% |
| 2032 | $9.0b | 5.00% |
| 2024 | 16.04% | 7.50% |
|---|---|---|
| 2025 | 20.40% | 27.15% |
| 2026 | 20.59% | 0.93% |
| 2027 | 20.87% | 1.36% |
| 2028 | 23.93% | 14.66% |
| 2029 | 24.82% | 3.72% |
| 2030 | 23.91% | 3.67% |
| 2031 | 24.33% | 1.76% |
| 2032 | 24.60% | 1.11% |
29 Marriott Analysts have issued a net profit forecast 2025. The average Marriott net profit estimate is $2.7b . This is 4.55% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 17.44% , the lowest is $2.6b 0.40% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $2.4b | 22.96% |
|---|---|---|
| 2025 | $2.7b | 14.94% |
| 2026 | $3.1b | 13.07% |
| 2027 | $3.5b | 13.03% |
| 2028 | $4.3b | 24.52% |
| 2029 | $4.9b | 12.72% |
| 2030 | $5.3b | 7.59% |
| 2031 | $5.6b | 7.23% |
| 2032 | $6.2b | 9.15% |
| 2024 | 9.46% | 27.22% |
|---|---|---|
| 2025 | 10.30% | 8.85% |
| 2026 | 11.03% | 7.09% |
| 2027 | 11.80% | 6.98% |
| 2028 | 14.48% | 22.71% |
| 2029 | 15.92% | 9.94% |
| 2030 | 15.34% | 3.64% |
| 2031 | 16.04% | 4.56% |
| 2032 | 16.87% | 5.17% |
29 Analysts have issued a Marriott forecast for earnings per share. The average Marriott EPS is $10.13 . This is 5.74% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.38 18.79% , the lowest is $9.65 0.73% .
This results in the following potential growth metrics and future valuations:
| 2024 | $8.33 | 18.17% |
|---|---|---|
| 2025 | $10.13 | 21.61% |
| 2026 | $11.46 | 13.13% |
| 2027 | $12.95 | 13.00% |
| 2028 | $16.12 | 24.48% |
| 2029 | $18.17 | 12.72% |
| 2030 | $19.55 | 7.59% |
| 2031 | $20.97 | 7.26% |
| 2032 | $22.89 | 9.16% |
| Current | 29.82 | 4.09% |
|---|---|---|
| 2025 | 28.20 | 5.45% |
| 2026 | 24.94 | 11.56% |
| 2027 | 22.06 | 11.55% |
| 2028 | 17.72 | 19.67% |
| 2029 | 15.72 | 11.29% |
| 2030 | 14.61 | 7.06% |
| 2031 | 13.63 | 6.71% |
| 2032 | 12.48 | 8.44% |
Based on analysts' sales estimates for 2025, the Marriott stock is valued at an EV/Sales of 3.47 and an P/S ratio of 2.89 .
This results in the following potential growth metrics and future valuations:
| Current | 3.55 | 3.79% |
|---|---|---|
| 2025 | 3.47 | 2.20% |
| 2026 | 3.29 | 5.28% |
| 2027 | 3.11 | 5.41% |
| 2028 | 3.07 | 1.43% |
| 2029 | 2.99 | 2.44% |
| 2030 | 2.68 | 10.44% |
| 2031 | 2.61 | 2.48% |
| 2032 | 2.52 | 3.69% |
| Current | 2.96 | 6.13% |
|---|---|---|
| 2025 | 2.89 | 2.16% |
| 2026 | 2.74 | 5.28% |
| 2027 | 2.59 | 5.41% |
| 2028 | 2.56 | 1.43% |
| 2029 | 2.49 | 2.43% |
| 2030 | 2.23 | 10.44% |
| 2031 | 2.18 | 2.48% |
| 2032 | 2.10 | 3.69% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Nov 05 2025 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Nov 05 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2025 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Oct 21 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 03 2025 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Sep 03 2025 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Aug 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Nov 05 2025 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Nov 05 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 22 2025 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Oct 21 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 03 2025 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Sep 03 2025 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Aug 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


